Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Astria Therapeutics Inc (NASDAQ: ATXS) closed the day trading at $9.27 down -2.32% from the previous closing price of $9.49. In other words, the price has decreased by -$2.32 from its previous closing price. On the day, 0.63 million shares were traded. ATXS stock price reached its highest trading level at $10.04 during the session, while it also had its lowest trading level at $9.25.
Ratios:
For a better understanding of ATXS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 33.83 and its Current Ratio is at 33.83. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Evercore ISI on March 28, 2023, initiated with a Outperform rating and assigned the stock a target price of $18.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 01 ’24 when Morabito Christopher sold 10,000 shares for $13.59 per share. The transaction valued at 135,939 led to the insider holds 0 shares of the business.
PERCEPTIVE ADVISORS LLC bought 2,481,350 shares of ATXS for $29,999,522 on Feb 01 ’24. The Director now owns 4,873,721 shares after completing the transaction at $12.09 per share. On Jan 29 ’24, another insider, Morabito Christopher, who serves as the Chief Medical Officer of the company, sold 9,200 shares for $11.15 each. As a result, the insider received 102,552 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATXS now has a Market Capitalization of 509044448 and an Enterprise Value of 234629072.
Stock Price History:
The Beta on a monthly basis for ATXS is 0.79, which has changed by -0.26252985 over the last 52 weeks, in comparison to a change of 0.2644323 over the same period for the S&P500. Over the past 52 weeks, ATXS has reached a high of $16.90, while it has fallen to a 52-week low of $4.26. The 50-Day Moving Average of the stock is -22.57%, while the 200-Day Moving Average is calculated to be 2.62%.
Shares Statistics:
Over the past 3-months, ATXS traded about 1.01M shares per day on average, while over the past 10 days, ATXS traded about 554470 shares per day. A total of 54.91M shares are outstanding, with a floating share count of 44.72M. Insiders hold about 18.56% of the company’s shares, while institutions hold 74.40% stake in the company. Shares short for ATXS as of 1714435200 were 4582487 with a Short Ratio of 4.52, compared to 1711584000 on 5059726. Therefore, it implies a Short% of Shares Outstanding of 4582487 and a Short% of Float of 8.67.
